Outcomes and late toxicities with ultra-hypofractionated radiation in non-metastatic prostate cancer

被引：0
|
作者：
Mallick, Ankita [1 ]
Shenoy, Shashank [1 ]
Arunsingh, Moses [1 ]
Mallick, Indranil [1 ]
机构：
[1] Tata Med Ctr, Radiat Oncol, Kolkata, India
来源：
RADIOTHERAPY AND ONCOLOGY | 2024年 / 194卷
关键词：
SBRT; Ultra-hypofractionation; Late toxicities;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1740
引用
收藏
页码：S2452 / S2453
页数：2
相关论文
共 50 条
  • [41] Ultra-hypofractionated SABR in High risk prostate cancer: preliminary results of a phase II trial
    Montero, A.
    Rossi, K.
    Hernando, O.
    Lopez, M.
    Valero, J.
    Canadillas, C.
    Chen-Zhao, X.
    Ciervide, R.
    Garcia-Aranda, M.
    Alvarez, B.
    Prado, A.
    Alonso, R.
    Sanchez, E.
    Izquierdo, M.
    Fernandez-Leton, P.
    Rubio, C.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1194 - S1195
  • [42] Quantitative MRI Changes During Weekly Ultra-Hypofractionated Prostate Cancer Radiotherapy With Integrated Boost
    van Schie, Marcel A.
    van Houdt, Petra J.
    Ghobadi, Ghazaleh
    Pos, Floris J.
    Walraven, Iris
    de Boer, Hans C. J.
    van den Berge, Cornelis A. T.
    Smeenk, Robert Jan
    Kerkmeijer, Linda G. W.
    van der Heide, Uulke A.
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [43] Impact of daily plan adaptation on accumulated doses in ultra-hypofractionated magnetic resonance-guided radiation therapy of prostate cancer
    Xiong, Yuqing
    Rabe, Moritz
    Rippke, Carolin
    Kawula, Maria
    Nierer, Lukas
    Klueter, Sebastian
    Belka, Claus
    Niyazi, Maximilian
    Hoerner-Rieber, Juliane
    Corradini, Stefanie
    Landry, Guillaume
    Kurz, Christopher
    PHYSICS & IMAGING IN RADIATION ONCOLOGY, 2024, 29
  • [44] EXTREME WEEKLY LOCO-REGIONAL HYPOFRACTIONATED RADIATION IN ELDERLY WOMEN WITH NON-METASTATIC BREAST CANCER
    Rais, Fadoua
    RADIOTHERAPY AND ONCOLOGY, 2021, 163 : S14 - S14
  • [45] Give-me-five trial: toxicity assessment in ultra-hypofractionated prostate cancer radiotherapy
    Ciardo, D.
    Marvaso, G.
    Gandini, S.
    Mambretti, M.
    Fodor, C.
    Zerini, D.
    Volpe, S.
    Riva, G.
    Rojas, D. P.
    Petralia, G.
    Cambria, R.
    Orecchia, R.
    Jereczek-Fossa, B. A.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S836 - S837
  • [46] Ultra-Hypofractionated Radiation in Older Patients with Low Risk Early-Stage Breast Cancer
    Gui, B.
    Ojo, O.
    Ottensoser, L.
    Talcott, W. J.
    Parashar, B.
    Potters, L.
    Wernicke, G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E310 - E310
  • [47] Clinical characteristics and survival outcomes in patients with a high PSA and non-metastatic prostate cancer
    Huang, Cheng-Yu
    Chen, Chung-Hsin
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2022, 121 (01) : 181 - 186
  • [48] Clinical characteristics and outcomes for patients with non-metastatic castration-resistant prostate cancer
    Arnold, Peter
    Penaloza-Ramos, Maria Cristina
    Adedokun, Lola
    Rees, Sarah
    Lockhat, Mohamed
    Spary, Lisa
    Watkins, Alan
    Gnanapragasam, Vincent
    Crabb, Simon J.
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [49] Combination hormone therapy for non-metastatic prostate cancer
    Ohlmann, Carsten
    Grunwald, V.
    Hadaschik, B.
    UROLOGIE, 2022, 61 (06): : 660 - 662
  • [50] Outcome of Treatment of Non-metastatic Prostate Cancer with Ultra-high PSA in Saskatchewan Canada
    Tai, P.
    Tonita, J.
    Joseph, K.
    Woitas, C.
    Skarsgard, D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S383 - S383
12345